Newsroom

Monarch Medical Technologies Shifts Market with Safest Insulin Therapy Treatment

EndoTool Dosing Recommendations Applauded by Hospitals

Monarch Medical Technologies, the safest provider of glucose management software, announces record growth and continues to shift the U.S. hospital market towards improved glucose management. In regards to insulin therapy treatment, studies show that hospital admission rates for hypoglycemia have begun to outpace hyperglycemia rates, demonstrating today’s largest needs for improving insulin therapy treatments. Hypoglycemia is one of the most common adverse effects of lowering blood glucose levels with insulin therapy in patients with diabetes, and the increase in these rates may be attributed to the lack of proper control in hyperglycemia. read more…

Monarch Medical Technologies Receives FDA 510(k) Clearance for EndoTool SubQ™

EndoTool SubQ Utilizes Clinically Proven and Patent Pending Model Predictive Control Technology to Determine the Safest Patient-Specific Basal/Bolus and Correction Subcutaneous Insulin Dose Recommendations

Monarch Medical Technologies, a medical technology company committed to safe insulin dosing, today announced that the US Food and Drug Administration (FDA) has cleared the company’s newest solution, EndoTool SubQ™. read more…

Monarch Medical Technologies Establishes Medical Advisory Board With Experts from Across Healthcare Continuum

Monarch Medical Technologies Establishes Medical Advisory Board With Experts from Across Healthcare Continuum

Monarch Medical Technologies, the pioneer and leader in clinical decision support for drug dosing in hospitalized patients, today announced that it has developed a medical advisory board to counsel the company on strategic areas of interest. The board includes members from both the U.S. and abroad, and leverages both healthcare and analytics experts. read more…

Monarch Medical Technologies Appoints Senior Vice President of Sales and Marketing

Monarch Medical Technologies, the pioneer and leader in clinical decision support for drug dosing in hospitalized patients, today announced that Glenn Petracci has joined the company as its new senior vice president of sales and marketing. Formerly the vice president of sales for Capsule Tech, Inc., Petracci brings more than 25 years of experience in both the clinical and business aspects of healthcare and information technology. read more…

Monarch Medical Technologies Announces New Chief Executive Officer

Monarch Medical Technologies, the pioneer and leader in mitigating risk associated with drug dosing in hospitalized patients, today announced that Stuart Long has joined the company as its new chief executive officer. Formerly the global chief marketing and sales officer for CapsuleTech, Inc., Long has extensive experience in driving corporate growth and strategic objectives. read more…

Monarch Medical Technologies Launches New EndoTool IV™ to Further Enhance Patient-Specific Glycemic Control in Hospitals

Next Generation Glucose Management Solution Offers Several New Features to Aid Healthcare  Professionals in Addressing the Most Complex Cases

Monarch Medical Technologies, the pioneer and leader in mitigating risk associated with drugs and processes of concern in hospitalized patients, today announced the U.S. Food and Drug Administration clearance of its new glucose management solution, EndoTool IV™. EndoTool IV is part of the EndoTool platform, a market-leading suite of blood glucose management software solutions recognized for the ability to provide unsurpassed patient-specific glycemic control across a broad population of patients. read more…

Monarch Medical Technologies Achieves ISO 13485 Certification

Monarch Medical Technologies, the pioneer and leader in mitigating risk associated with drugs and processes of concern in hospitalized patients, has earned ISO 13485:2003 certification for its quality management system from the independent certifying body, Nemko. The international quality standard containing multiple criteria for the whole range of a medical device manufacturer’s quality management system, ISO 13485:2003 certifies Monarch’s ability to offer medical devices and related services that consistently meet applicable customer needs and regulatory requirements. read more…

Study: EndoTool Glucose Management System Boosts Vidant Medical Center’s Surgical Care Improvement Project Scores, Doubles Cost Savings in Hospital Acquired Conditions

A late-breaking poster presented at the 73rd Scientific Sessions of the American Diabetes Association by Greenville, N.C.-based Vidant Medical Center, the flagship hospital for Vidant Health and the teaching hospital for the Brody School of Medicine at East Carolina University, has demonstrated that implementing the EndoTool Glucose Management System resulted in controlled and sustained improvements in blood sugar levels among patients. read more…

Private Investment Firm Eigen Capital Unveils Monarch Medical Technologies, New Corporate Entity Behind Market-Leading EndoTool™ Solution

Company Focused on Helping Hospitals and Health Systems Mitigate Risk  Associated with Drugs and Processes of Concern

Palo Alto, Calif.-based private investment firm Eigen Capital LLC, which acquired the EndoTool business from Hospira Worldwide in September 2012, today unveiled the company’s new identity as Monarch Medical Technologies. The announcement comes as the company makes its first public debut at the 2013 National Teaching Institute & Critical Care Exposition being held May 20–23, 2013, in Boston (Booth #1654). read more…

Page 3 of 3123

CTA

Quick Links

Press Releases

In the News

 

Don’t Miss A Thing

Headquarters
2137 South Blvd, Suite 300, Charlotte, NC 28203

 

Media Contact
marketing@monarchmedtech.com

 

Media Kit 2016 | Monarch Medical Technologies